Correction: Tranexamic acid in patients undergoing coronary-artery surgery (New England Journal of Medicine (2017) 376 (136-148) DOI: 10.1056/NEJMoa1606424);Tranexamic acid in patients undergoing coronary-artery surgery

New England Journal of Medicine

Volumn 376, Issue 2, 2017, Pages 136-148

  Myles, Paul S ^a,b   Smith, Julian A ^b   Forbes, Andrew ^b   Silbert, Brendan ^c   Jayarajah, Mohandas ^b   Painter, Thomas ^d   Cooper, D James ^a,b   Marasco, Silvana ^a,b   McNeil, John ^e   Bussieres, Jean S ^f   McGuinness, Shay ^g   Byrne, Kelly ^h   Chan, Matthew T V ⁱ   Landoni, Giovanni ^j   Wallace, Sophie ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e DERRIFORD HOSPITAL   (United Kingdom)

^f LAVAL UNIVERSITY   (Canada)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h WAIKATO HOSPITAL   (New Zealand)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DOUBLE BLIND PROCEDURE; FACTORIAL DESIGN; FEMALE; HEART INFARCTION; HEART TAMPONADE; HUMAN; INTESTINE INFARCTION; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SEIZURE; SURGICAL MORTALITY; CHEMICALLY INDUCED; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART VALVE; HEMORRHAGE; INTRAOPERATIVE COMPLICATIONS; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; STATISTICS AND NUMERICAL DATA; THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ASPIRIN; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEART VALVES; HEMORRHAGE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; REOPERATION; SEIZURES; THROMBOSIS; TRANEXAMIC ACID;

EID: 85009274687     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMx180005     Document Type: Erratum

References (29)

1. Robich MP, Koch CG, Johnston DR, et al. Trends in blood utilization in United States cardiac surgical patients. Transfusion 2015; 55: 805-14.
2. Biancari F, Mikkola R, Heikkinen J, Lahtinen J, Airaksinen KE, Juvonen T. Estimating the risk of complications related to re-exploration for bleeding after adult cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012; 41: 50-5.
3. Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical reexploration after cardiac operations: why a worse outcome? Ann Thorac Surg 2008; 86: 1557-62.
4. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; 3: CD001886.
5. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
6. Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998; 116: 716-30.
7. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354: 353-65.
8. Risch A, Dorscheid E, Stein G, Seyfert UT, Grundmann U. The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass. Anaesthesist 2000; 49: 279-85. (In German.)
9. Dentz ME, Slaughter TF, Mark JB. Early thrombus formation on heparinbonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. Anesthesiology 1995; 82: 583-6.
10. Garg J, Pinnamaneni S, Aronow WS, Ahmad H. ST elevation myocardial infarction after tranexamic acid: first reported case in the United States. Am J Ther 2014; 21(6): e221-4.
11. Stief TW. Tranexamic acid triggers thrombin generation. Hemost Lab 2009; 2: 73-82.
12. Ngaage DL, Bland JM. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 2010; 37: 1375-83.
13. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-3.
14. Tsementzis SA, Meyer CH, Hitchcock ER. Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid. Neurochirurgia (Stuttg) 1992; 35: 74-8.
15. Baharoglu MI, Germans MR, Rinkel GJ, et al. Antifibrinolytic therapy for an-eurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2013; 8: CD001245.
16. Myles PS, Smith J, Knight J, et al. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J 2008; 155: 224-30.
17. Myles PS, Smith JA, Forbes A, et al. Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med 2016; 374: 728-37.
18. Dowd NP, Karski JM, Cheng DC, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97: 390-9.
19. Sharma V, Katznelson R, Jerath A, et al. The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia 2014; 69: 124-30.
20. Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth 2012; 59: 6-13.
21. Keyl C, Uhl R, Beyersdorf F, et al. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg 2011; 39(5): e114-21.
22. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126: 2020-35.
23. Thielmann M, Massoudy P, Schmermund A, et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 2005; 26: 2440-7.
24. Mohammed AA, Agnihotri AK, van Kimmenade RR, et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 2009; 120: 843-50.
25. Fransen EJ, Diris JH, Maessen JG, Hermens WT, van Dieijen-Visser MP. Evaluation of "new" cardiac markers for ruling out myocardial infarction after coronary artery bypass grafting. Chest 2002; 122: 1316-21.
26. Grassin-Delyle S, Tremey B, Abe E, et al. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth 2013; 111: 916-24.
27. Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31.
28. Sigaut S, Tremey B, Ouattara A, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2014; 120: 590-600.
29. Goldstone AB, Bronster DJ, Anyanwu AC, et al. Predictors and outcomes of seizures after cardiac surgery: a multivariable analysis of 2,578 patients. Ann Thorac Surg 2011; 91: 514-8.